jrnls.org logo
Submit

BROWSE ALL JOURNALS

SEE ALL 19 JOURNALS
Pharmacognosy MagazineNOW IN
Article

Curcumin Regulates Lipid Mobilization Factors Through S100A9 in Patients With Anorexia– Cachexia Syndrome in Head and Neck Cancer

Shujing Qi1, Gaixia Fu2, Zhaozhen Chu3★★ Corresponding author

  1. 1Department of Nutrition, Affiliated Hospital of Hebei University of Engineering, Handan, Hebei, CHINA.
  2. 2Department of Gastroenterology, Affiliated Hospital of Hebei University of Engineering, Handan, Hebei, CHINA.
  3. 3Department of General Surgery, Affiliated Hospital of Hebei University of Engineering, Handan, Hebei, CHINA.

CORRESPONDENCE

Zhaozhen Chu

Department of General Surgery, Affiliated Hospital of Hebei University of Engineering, Handan, Hebei, CHINA.

zlwzlw2000@126.com

Received: 25-09-2024; Accepted: 31-01-2025.

Volume 22, Issue 1 · pp. 43–52 · PUBLISHED 2026 · DOI: 10.1177/09731296251330001

View on PM original site ↗

ABSTRACT

Background: Anorexia–cachexia syndrome in head and neck cancer (ACSHNC) seriously affects the patient’s quality of life and prognosis. Curcumin inhibits head and neck cancer and anorexic cachexia syndrome. S100A9 is related to tumors, but its role in ACSHNC requires further study. Objectives: This study intends to investigate the role of S100A9 in ACSHNC. Materials and Methods: In this study, subjects were randomly divided into negative control (NC) group, low-, medium-, and high-dose curcumin groups, and cell proliferation was detected; flow cytometry detected cell apoptosis; Western blot detected CyclinB1, P21, DR5, and DR4, cleaved caspase-9, cleaved poly (ADP-ribose) polymerase (PARP), and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) protein expression along with analysis of serum albumin and prealbumin levels. Results: Before treatment, the patient had obvious symptoms such as loss of appetite, weight loss, and fatigue, and levels of lipid mobilization factors and S100A9 in plasma were significantly increased. After curcumin treatment, the patient’s symptoms improved considerably, and the levels of lipid mobilization factors and S100A9 in plasma were reduced. In addition, urinary excretion of lipid mobilization factors was also reduced. Conclusion: Curcumin can improve the symptoms and prognosis of patients with ACSHNC by regulating lipid mobilization factors and S100A9 levels, indicating that it might be utilized as a new possibility for ACSHNC treatment.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Qi, S., Fu, G., & Chu, Z. (2026). Curcumin Regulates Lipid Mobilization Factors Through S100A9 in Patients With Anorexia– Cachexia Syndrome in Head and Neck Cancer. Pharmacognosy Magazine, 22(1), 43–52. https://doi.org/10.1177/09731296251330001